Correlation between balloon release pressure and no-reflow in patients with acute myocardial infarction undergoing direct percutaneous coronary intervention

被引:1
作者
Wang Yanfei [1 ]
Yao Min [2 ,3 ,4 ]
Liu Haibo [2 ,3 ,4 ]
Yang Yuejin [2 ,3 ,4 ]
Xie Junmin [1 ]
Jia Xinwei [1 ]
Pan Huanjun [1 ]
Wang Chunyan [1 ]
机构
[1] Hebei Univ, Affiliated Hosp, Dept Cardiovasc Dis, Baoding 071000, Hebei, Peoples R China
[2] Chinese Acad Med Sci, Cardiovasc Inst, Dept Cardiovasc Dis, Beijing 100037, Peoples R China
[3] Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100037, Peoples R China
[4] Peking Union Med Coll, Beijing 100037, Peoples R China
关键词
acute myocardial infarction; percutaneous coronary intervention; balloon; pressure; no-reflow phenomenon; MAJOR DEPRESSION; ADENOSINE; ASSOCIATION; REPERFUSION; GUIDELINES; THERAPY; INJURY;
D O I
10.3760/cma.j.issn.0366-6999.20133002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Balloon release pressure may increase the incidence of no reflow after direct percutaneous coronary intervention (PCI). This randomized controlled study was designed to analyze the correlation between balloon release pressure and no-reflow in patients with acute myocardial infarction (AMI) undergoing direct PCI. Methods There were 156 AMI patients who underwent PCI from January 1, 2010 to December 31, 2012, and were divided into two groups according to the stent inflation pressure: a conventional pressure group and a high pressure group. After PCI, angiography was conducted to assess the thrombolysis in myocardial infarction (TIMI) grade with related artery. Examinations were undertaken on all patients before and after the operation including cardiac enzymes, total cholesterol, low-density lipoprotein, blood glucose, homocysteine, beta-thromboglobulin (beta-TG), Hamilton depression scale (HAMD) and self-rating anxiety scale (SAS). After interventional therapy, the afore-mentioned parameters in both the conventional pressure group and high pressure group were again analyzed. Results The results showed that CK-MB, HAMD, SAS were significantly different (P <0.05) in all patients after PCI, especially the CK-MB in the high pressure group ((25.7 +/- 7.6) U/L vs. (76.7 +/- 11.8) U/L). CK-MB, HAMD, SAS, and beta-TG were comparative before PCI but they were significantly changed (P <0.05) after intervention. No-reflow phenomenon occurred in 13 patients in the high pressure group, which was significantly higher than in the conventional pressure group (17.11% vs. 6.25%, P <0.05). Conclusion In stent implantation, using a pressure less than 1823.4 kPa balloon to release pressure may be the better choice to reduce the occurrence of no-reflow following direct PCI.
引用
收藏
页码:1008 / 1011
页数:4
相关论文
共 25 条
  • [1] Ari H, 2010, TURK KARDIYOL DERN A, V38, P327
  • [2] Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection
    Babu, Girish Ganesha
    Walker, J. Malcolm
    Yellon, Derek M.
    Hausenloy, Derek J.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 (01) : 23 - +
  • [3] Microvascular Obstruction Underlying Pathophysiology and Clinical Diagnosis
    Bekkers, Sebastiaan C. A. M.
    Yazdani, Saami K.
    Virmani, Renu
    Waltenberger, Johannes
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (16) : 1649 - 1660
  • [4] Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality
    Brosh, David
    Assali, Abid R.
    Mager, Aviv
    Porter, Avital
    Hasdai, David
    Teplitsky, Igal
    Rechavia, Eldad
    Fuchs, Shmuel
    Battler, Alexander
    Kornowski, Ran
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (04) : 442 - 445
  • [5] Butkiewicz Anna Maria, 2003, Kardiol Pol, V58, P449
  • [6] High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction
    Desmet, Walter
    Bogaert, Jan
    Dubois, Christophe
    Sinnaeve, Peter
    Adriaenssens, Tom
    Pappas, Christos
    Ganame, Javier
    Dymarkowski, Steven
    Janssens, Stefan
    Belmans, Ann
    Van de Werf, Frans
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 (07) : 867 - 877
  • [7] Kang S, 2007, CLIN INVEST MED, V30, pE133
  • [8] Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
    Keeley, EC
    Boura, JA
    Grines, CL
    [J]. LANCET, 2003, 361 (9351) : 13 - 20
  • [9] The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes
    Lespérance, F
    Frasure-Smith, N
    Théroux, P
    Irwin, M
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (02) : 271 - 277
  • [10] 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
    Levine, Glenn N.
    Bates, Eric R.
    Blankenship, James C.
    Bailey, Steven R.
    Bittl, John A.
    Cercek, Bojan
    Chambers, Charles E.
    Ellis, Stephen G.
    Guyton, Robert A.
    Hollenberg, Steven M.
    Khot, Umesh N.
    Lange, Richard A.
    Mauri, Laura
    Mehran, Roxana
    Moussa, Issam D.
    Mukherjee, Debabrata
    Nallamothu, Brahmajee K.
    Ting, Henry H.
    Jacobs, Alice K.
    Anderson, Jeffrey L.
    Albert, Nancy
    Creager, Mark A.
    Ettinger, Steven M.
    Guyton, Robert A.
    Halperin, Jonathan L.
    Hochman, Judith S.
    Kushner, Frederick G.
    Ohman, E. Magnus
    Stevenson, William
    Yancy, Clyde W.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 82 (04) : E266 - E355